There was a time when the term "Buy Now Pay Later" or BNPL was associated exclusively with fashion, electronics, or online shopping. You bought a new pair of shoes and paid in four installments. But in 2026, the landscape has transformed completely. Across the United Kingdom and various parts of Europe, people are now using BNPL to cover healthcare costs. Dental treatments, prescription glasses, diagnostic scans, and in some cases even surgical procedures are being paid for in installments. This trend is accelerating rapidly. But the critical question remains: is this genuinely improving access to healthcare, or is it creating a new type of debt trap for patients?
Understanding why this subject matters right now requires looking at two numbers. First, across Europe, waiting lists for public health insurance systems or the NHS have reached record-breaking levels. Second, the rising cost of living has left ordinary people with limited cash on hand. When an urgent medical need arises, patients face an impossible choice between long NHS waiting lists and expensive private hospital bills. BNPL has emerged as a middle path. It is no longer just a shopping tool; it has become a financial instrument through which people are prioritizing their health, even if that means taking on debt.
The UK market shows this trend most clearly. Clinics like Fusion HealthCare have already partnered with Clearpay to allow patients to split their medical bills into four equal installments. The process is remarkably simple. You open an account, the clinic sends a payment link for your bill, and after paying the first installment, you receive treatment. The remaining amount is automatically deducted every two weeks. The most attractive feature is that if you pay on time, there is no interest or additional charges. The only warning is that missed payments incur penalties, such as a £6 fee per missed payment with Clearpay
This is not limited to cosmetic or dental treatments. A survey by Weave found that approximately 47% of Gen Z consumers are already using BNPL to cover healthcare costs. According to 2023 data, 11% of Baby Boomers paid over $7,500 out of pocket for medical bills, demonstrating that this is not exclusively a young generation's problem. The biggest shift is in mindset. 65% of Gen Z and 54% of Millennials believe that having BNPL options would prevent them from delaying medical care. This means this financial tool directly impacts public health—people are no longer avoiding treatment solely due to financial constraints.
However, beneath this apparent convenience lies a complex equation involving economics and health. The year 2026 represents a turning point for BNPL, as European and UK governments are bringing this sector under strict regulatory control. Where BNPL was previously an "unregulated" sector, the European Union's new Consumer Credit Directive (CCD2) now makes it mandatory to verify whether a person has the ability to repay the loan before they can purchase anything in installments. This means simply opening an app and entering a name and address is no longer sufficient. Providers must examine bank balances, income, and regular spending patterns.
The United Kingdom is taking even stricter measures. From July 15, 2026, "Deferred Payment Credit" (what we know as BNPL) will come directly under the jurisdiction of the Financial Conduct Authority (FCA). This means companies offering medical bill installments must now obtain an FCA license. They will be able to check customer credit records, and if someone fails to pay, it will damage their credit score. According to FCA calculations, despite business costs, consumers will save at least £440 million in late fees and reduce the mental stress of falling into debt once these regulations take effect.
The question now is how these regulations will impact the healthcare sector. The first effect will be on lending transparency. Clinics will now have to verify more strictly whether patients can genuinely repay the installments. Where "pre-approval" was previously given without any affordability checks, that will no longer be possible. This creates a double-edged sword for healthcare. On one hand, it protects patients from excessive debt burdens. For example, if someone knows their income will decrease over the next three months, strict checks might lead them to delay treatment or choose more affordable options. On the other hand, it could fundamentally change business models for dental or ophthalmology clinics, as stricter regulations may mean many patients no longer qualify.
The biggest tragedy of BNPL in healthcare relates to health equity. Looking at the data, 46% of people rank healthcare as their biggest financial priority after food and housing. When BNPL is not available, people ignore tooth pain or other symptoms while trying to save money for rent or food. BNPL fills this gap. But when regulations become stricter, those with poor credit scores or irregular incomes (such as delivery workers or freelancers) will be excluded from this option. This could create a two-tier health system those with good credit cards and bank balances can access installment-based treatment, while those without regular income proof return to long NHS waiting lists.
Another major change in Europe is the use of open banking. Under the CCD2 law, BNPL providers must now check in real time whether a patient actually has the money in their bank account to pay installments. This could bring a revolutionary change to the healthcare sector. For example, if a cancer patient needs urgent treatment but has a low bank balance, open banking-based data might allow providers to offer special concessions. However, there are negative aspects as well. Patients already have sensitive health data, and now financial data is being added. Having both types of data with a single company represents a significant privacy risk.
The future of BNPL in healthcare depends on the coming weeks around July 15, 2026, when the FCA regulations take effect. Already, 24% of consumers are using BNPL, with the highest demand in dental and primary care sectors. Major European health tech companies are currently in a wait-and-see mode. Some believe stricter regulations will shrink this market. Others see it as an opportunity for "responsible lending" and a major business opportunity.
For patients considering this option, the most important task now is to read the fine print. Companies like Clearpay may claim no interest, but a single missed payment can ruin your credit record. In the coming days, "pay later healthcare" will no longer be just an affordable option; it is a financial product. And like any financial product, understanding the risks before taking advantage of the benefits is essential. European health policy now stands at a crossroads. Policymakers do not want healthcare to become a commercial product, but they also do not want ordinary people to die due to lack of money. The second half of 2026 will see major debates on this issue, particularly in Germany and France, which have not yet taken strict positions on BNPL in healthcare. For now, countries like the United Kingdom and Bulgaria continue their experiments.